Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The effectiveness of eight nonpharmaceutical interventions against COVID-19 in 41 countries

Jan M. Brauner, Sören Mindermann, Mrinank Sharma, Anna B. Stephenson, Tomáš Gavenčiak, David Johnston, Gavin Leech, John Salvatier, George Altman, Alexander John Norman, Joshua Teperowski Monrad, Tamay Besiroglu, Hong Ge, Vladimir Mikulik, Meghan A. Hartwick, Yee Whye Teh, Leonid Chindelevitch, Yarin Gal, Jan Kulveit
doi: https://doi.org/10.1101/2020.05.28.20116129
Jan M. Brauner
1OATML, Department of Computer Science, University of Oxford, Oxford, United Kingdom.
2Future of Humanity Institute, University of Oxford, Oxford, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jan.brauner@eng.ox.ac.uk
Sören Mindermann
1OATML, Department of Computer Science, University of Oxford, Oxford, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mrinank Sharma
3Department of Computer Science, University of Oxford, Oxford, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna B. Stephenson
4Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomáš Gavenčiak
5No affiliation.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Johnston
6College of Engineering and Computer Science, Australian National University, Australia.
7Quantified Uncertainty Research Institute, California, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin Leech
8School of Computer Science, University of Bristol, Bristol, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Salvatier
7Quantified Uncertainty Research Institute, California, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Altman
9School of Medical Sciences, University of Manchester, Manchester, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander John Norman
5No affiliation.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joshua Teperowski Monrad
2Future of Humanity Institute, University of Oxford, Oxford, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamay Besiroglu
10Faculty of Economics, University of Cambridge, Cambridge, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Ge
11Engineering Department, University of Cambridge, Cambridge, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Mikulik
5No affiliation.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Meghan A. Hartwick
12Tufts Initiative for the Forecasting and Modeling of Infectious Diseases, Tufts University, Boston, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yee Whye Teh
13Department of Statistics, University of Oxford, Oxford, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonid Chindelevitch
14Computational Epidemiology Lab, School of Computing Science, Simon Fraser University, Burnaby, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yarin Gal
1OATML, Department of Computer Science, University of Oxford, Oxford, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Kulveit
2Future of Humanity Institute, University of Oxford, Oxford, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Governments are attempting to control the COVID-19 pandemic with nonpharmaceutical interventions (NPIs). However, it is still largely unknown how effective different NPIs are at reducing transmission. Data-driven studies can estimate the effectiveness of NPIs while minimizing assumptions, but existing analyses lack sufficient data and validation to robustly distinguish the effects of individual NPIs.

Methods We collect chronological data on NPIs in 41 countries between January and May 2020, using independent double entry by researchers to ensure high data quality. We estimate NPI effectiveness with a Bayesian hierarchical model, by linking NPI implementation dates to national case and death counts. To our knowledge, this is the largest and most thoroughly validated data-driven study of NPI effectiveness to date.

Results We model each NPI’s effect as a multiplicative (percentage) reduction in the reproduction number R. We estimate the mean reduction in R across the countries in our data for eight NPIs: mandating mask-wearing in (some) public spaces (2%; 95% CI: −14%–16%), limiting gatherings to 1000 people or less (2%; −20%–22%), to 100 people or less (21%; 1%–39%), to 10 people or less (36%; 16%–53%), closing some high-risk businesses (31%; 13%–46%), closing most nonessential businesses (40%; 22%–55%), closing schools and universities (39%; 21%–55%), and issuing stay-at-home orders (18%; 4%–31%). These results are supported by extensive empirical validation, including 15 sensitivity analyses.

Conclusions Our results suggest that, by implementing effective NPIs, many countries can reduce R below 1 without issuing a stay-at-home order. We find a surprisingly large role for school and university closures in reducing COVID-19 transmission, a contribution to the ongoing debate about the relevance of asymptomatic carriers in disease spread. Banning gatherings and closing high-risk businesses can be highly effective in reducing transmission, but closing most businesses only has limited additional benefit.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Jan Brauner was supported by the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems [EP/S024050/1] and by Cancer Research UK. Soeren Mindermann's funding for graduate studies was from Oxford University and DeepMind. Mrinank Sharma was supported by the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems [EP/S024050/1]. Gavin Leech was supported by the UKRI Centre for Doctoral Training in Interactive Artificial Intelligence [EP/S022937/1]. The paid contractor work in the data collection and the development of the interactive website was funded by the Berkeley Existential Risk Initiative.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This work was conducted in association with the EpidemicForecasting.org project

  • c This is only approximately true. The negative binomial output distribution has a coefficient of variation diminishing with its mean; i.e., smaller observations are relatively more noisy and carry less weight. Further-more, whilst the prior over Embedded Image could break scale invariance, the uninformative prior results in a negligible effect.

Data Availability

All NPI data with sources and model code are available at https://github.com/epidemics/COVIDNPIs/tree/paper

https://github.com/epidemics/COVIDNPIs/tree/paper

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted July 23, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The effectiveness of eight nonpharmaceutical interventions against COVID-19 in 41 countries
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The effectiveness of eight nonpharmaceutical interventions against COVID-19 in 41 countries
Jan M. Brauner, Sören Mindermann, Mrinank Sharma, Anna B. Stephenson, Tomáš Gavenčiak, David Johnston, Gavin Leech, John Salvatier, George Altman, Alexander John Norman, Joshua Teperowski Monrad, Tamay Besiroglu, Hong Ge, Vladimir Mikulik, Meghan A. Hartwick, Yee Whye Teh, Leonid Chindelevitch, Yarin Gal, Jan Kulveit
medRxiv 2020.05.28.20116129; doi: https://doi.org/10.1101/2020.05.28.20116129
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
The effectiveness of eight nonpharmaceutical interventions against COVID-19 in 41 countries
Jan M. Brauner, Sören Mindermann, Mrinank Sharma, Anna B. Stephenson, Tomáš Gavenčiak, David Johnston, Gavin Leech, John Salvatier, George Altman, Alexander John Norman, Joshua Teperowski Monrad, Tamay Besiroglu, Hong Ge, Vladimir Mikulik, Meghan A. Hartwick, Yee Whye Teh, Leonid Chindelevitch, Yarin Gal, Jan Kulveit
medRxiv 2020.05.28.20116129; doi: https://doi.org/10.1101/2020.05.28.20116129

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (72)
  • Allergy and Immunology (173)
  • Anesthesia (51)
  • Cardiovascular Medicine (465)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (163)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (198)
  • Epidemiology (5395)
  • Forensic Medicine (3)
  • Gastroenterology (200)
  • Genetic and Genomic Medicine (793)
  • Geriatric Medicine (82)
  • Health Economics (218)
  • Health Informatics (718)
  • Health Policy (372)
  • Health Systems and Quality Improvement (227)
  • Hematology (100)
  • HIV/AIDS (169)
  • Infectious Diseases (except HIV/AIDS) (6086)
  • Intensive Care and Critical Care Medicine (372)
  • Medical Education (110)
  • Medical Ethics (25)
  • Nephrology (85)
  • Neurology (797)
  • Nursing (43)
  • Nutrition (137)
  • Obstetrics and Gynecology (149)
  • Occupational and Environmental Health (242)
  • Oncology (486)
  • Ophthalmology (156)
  • Orthopedics (41)
  • Otolaryngology (101)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (143)
  • Pediatrics (230)
  • Pharmacology and Therapeutics (141)
  • Primary Care Research (101)
  • Psychiatry and Clinical Psychology (889)
  • Public and Global Health (2096)
  • Radiology and Imaging (363)
  • Rehabilitation Medicine and Physical Therapy (161)
  • Respiratory Medicine (293)
  • Rheumatology (98)
  • Sexual and Reproductive Health (76)
  • Sports Medicine (79)
  • Surgery (112)
  • Toxicology (25)
  • Transplantation (32)
  • Urology (40)